Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Jensen, L. J. N., Denner, L., Schrijvers, B., Tilton, R. G., Rasch, R. & Flyvbjerg, A. (2006). Renal effects of a neutralizing RAGE-antibody in long-term diabetic diabetic STZ-mice. J. Endocrinol., 188, 493-501.

Jensen, J. G. & Haa, B. P. (2006). Sygeplejediagnoser som kommunikation. Sygeplejersken, (23).

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis. Journal of Hepatology, 45((6)), 797-804.

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis. Abstract from Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis, 42nd EASD Annual Meeting, Denmark.

Jones, S. E., White, K. E., Flyvbjerg, A. & Marshall, S. M. (2006). The effect of intra-uterine environment and low glomerular number on the histological changes of diabetic glomerulosclerosis. Diabetologia, 49(1), 191-199.

Jørgensen, J. O. L. (2006). A simple twist of science: the convoluted tale of ghrelin continues. Journal of Clinical Endocrinology and Metabolism, 91, 3279-3280.

Jørgensen, J. O. L., Jessen, N., Pedersen, S. B., Vestergaard, E. T., Gormsen, L. C., Lund, S. & Billestrup, N. (2006). GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. American Journal of Physiology: Endocrinology and Metabolism, 291(5), E899-905.

Jørgensen, J. O. L. (2006). Growth hormone administration and exercise capacity. International Growth Monitor, 16, 21-23.

Jørgensen, J. O. L. (2006). Prediction of long-term responsiveness to somatostatin analogue treatment in acromegaly. International Growth Monitor, 16, 25-26.

Juncker-Jensen, A., Lykkesfeldt, A. E., Worm, J., Ralfkiaer, U., Espelund, U. & Jepsen, J. S. (2006). Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Growth Hormone and IGF Research, 16(4), 224-39. https://doi.org/10.1016/j.ghir.2006.06.005

Displaying results 3501 to 3510 out of 4099

351

Revised 11.09.2025

-

Department of Clinical Medicine